MedTrace Logo

Comparison of MMFS Dosages in Older Adults

NCT03601169 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2020-09-09

No results posted yet for this study

Summary

This study is designed to compare the effectiveness of different doses of brain health supplement MMFS relative to placebo on cognition, mood, and sleep quality.

Conditions

Interventions

DIETARY_SUPPLEMENT

Low Dose MMFS-205-SR

Twice daily, oral 500mg tablets

DIETARY_SUPPLEMENT

High Dose MMFS-205-SR

Twice daily, oral 500mg tablets

DIETARY_SUPPLEMENT

Placebo

Twice daily, oral

Sponsors & Collaborators

  • Neurocentria, Inc.

    lead INDUSTRY

Principal Investigators

  • Donald Burkindine, MD · Bio-Kinetic Clinical Applications, LLC

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
60 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-23
Primary Completion
2019-01-31
Completion
2019-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03601169 on ClinicalTrials.gov